1.Antiphospholipid Antibody Syndrome.
Journal of the Korean Medical Association 1998;41(3):340-346
No abstract available.
Antibodies, Antiphospholipid*
;
Antiphospholipid Syndrome*
2.Combined spinal-epidural anesthesia in a mild thrombocytopenic patient with antiphospholipid antibody syndrome.
Gahyun KIM ; Hyunyee SIM ; Jaeyoung YANG ; Jong Hwan LEE ; Duck Hwan CHOI
Korean Journal of Anesthesiology 2014;67(Suppl):S100-S101
No abstract available.
Anesthesia*
;
Antiphospholipid Syndrome*
;
Humans
3.Antithrombotic effects of hydroxychloroquine in a pregnant patient with Antiphospholipid syndrome and recurrent venous thromboembolism
Syang Pyng Gan ; Swee Gaik Ong
The Medical Journal of Malaysia 2017;72(2):124-125
A pregnant woman with antiphospholipid syndrome
presented with repeated venous thromboembolism (VTE) in
the first and second trimesters of pregnancy despite
receiving combination therapy with low-molecular-weight
heparin and aspirin. The addition of hydroxychloroquine
prevented further VTE recurrence, thus demonstrating its
potential antithrombotic effects.
Antiphospholipid Syndrome
;
Pregnant Women
5.Successful Treatment of Livedoid Vasculitis with Primary Antiphospholipid Syndrome by Using Aspirin and Low Dose Warfarin Combination Therapy.
Byoung Joon SO ; Jae Beom PARK ; Min Gun YOO ; Il Hwan KIM ; Sang Wook SON
Annals of Dermatology 2015;27(5):614-615
No abstract available.
Antiphospholipid Syndrome*
;
Aspirin*
;
Vasculitis*
;
Warfarin*
6.Successful Treatment of Livedoid Vasculitis with Primary Antiphospholipid Syndrome by Using Aspirin and Low Dose Warfarin Combination Therapy.
Byoung Joon SO ; Jae Beom PARK ; Min Gun YOO ; Il Hwan KIM ; Sang Wook SON
Annals of Dermatology 2015;27(5):614-615
No abstract available.
Antiphospholipid Syndrome*
;
Aspirin*
;
Vasculitis*
;
Warfarin*
7.A Case of Mixed connective tissue disease associated with antiphospholipid antibody syndrome.
Je Kyung LEE ; Sung Soo JUNG ; Tae Seok YOO ; Seung Chul SHIM ; Dae Kook CHANG ; Hee Kwan KOH ; Tae Hwan KIM ; Jae Bum JUN ; Sang Cheol BAE ; Dae Hyun YOO ; Seong Yoon KIM
The Journal of the Korean Rheumatism Association 1998;5(2):243-248
No abstract available.
Antibodies, Antiphospholipid*
;
Antiphospholipid Syndrome*
;
Mixed Connective Tissue Disease*
8.Antiphospholipid antibody role in Acute Ischemic Stroke patients with COVID-19: A narrative review
Arnaz Adisaputra ; Salsa Nurfadilla ; Andry Gonius
Acta Medica Philippina 2022;56(13):5-11
Antiphospholipid antibodies (aPL) are commonly found in humans after an infection. Its action can promote thrombosis via the activation of endothelial cells, platelets, and neutrophils. This autoantibody is the leading cause of antiphospholipid antibody syndrome (APS), characterized by widespread thrombosis in various vascular beds. COVID-19 also causes acute ischemic stroke (AIS) in the younger demographic, who previously was not considered a population at risk for AIS, which may be related to APS. This narrative review will discuss the role of aPL in COVID-19 patients who experienced AIS during infection.
Ischemic Stroke
;
COVID-19
;
Antiphospholipid Syndrome
;
Antibodies, Antiphospholipid
9.One case of Budd-Chiari syndrome secondary to antiphospholipid syndrome.
Xiaojie ZHAO ; Beijing 100038, CHINA ; Kuiliang LIU ; Beijing 100038, CHINA. ; Jing WU ; Beijing 100038, CHINA. ; Hong LIU ; Beijing 100038, CHINA. ; Xiangchun LIN ; Beijing 100038, CHINA. ; Yong LIU ; Beijing 100038, CHINA.
Chinese Journal of Hepatology 2016;24(2):140-142
10.Antiphospholipid Syndrome Associated with Adenocarcinoma.
Eun Jung CHOI ; Sun Uck KWON ; Jong Sung KIM
Journal of the Korean Neurological Association 2001;19(6):648-650
An antiphospholipid syndrome (APS) is a thrombotic disorder characterized by arterial or venous thrombosis with the presence of antiphospholipid antibodies (aPLs). APS may be associated with systemic lupus erythematosus, various hematologic diseases or neoplastic disorders. We describe a patient with APS, associated with adenocarcinoma, who had developed recurrent arterial/venous thrombosis that did not respond to anticoagulation treatment.
Adenocarcinoma*
;
Antibodies, Antiphospholipid
;
Antiphospholipid Syndrome*
;
Hematologic Diseases
;
Humans
;
Lupus Erythematosus, Systemic
;
Thrombosis
;
Venous Thrombosis
Result Analysis
Print
Save
E-mail